Control of myeloid differentiation and survival by Stats - PubMed (original) (raw)

Review

. 2000 May 15;19(21):2612-8.

doi: 10.1038/sj.onc.1203477.

Affiliations

• PMID: 10851060
• DOI: 10.1038/sj.onc.1203477

Review

Control of myeloid differentiation and survival by Stats

T E Smithgall et al. Oncogene. 2000.

Abstract

Hematopoiesis involves a complex array of growth factors that regulate the survival and proliferation of immature progenitors, influence differentiation commitment, and modulate end-stage cell functions. This mini-review is focused on the role of Stat activation in the development of myeloid cells in response to hematopoietic cytokines. Much of the evidence implicating Stats in these cellular processes comes from studies of mutant cytokine receptors selectively uncoupled from Stat activation, dominant-inhibitory Stat mutants, and mice with targeted disruptions of Stat genes. Together these approaches provide strong evidence that Stat activation, particularly of Stat3 and Stat5, plays an important role in myeloid differentiation and survival. Oncogene (2000).

PubMed Disclaimer

Similar articles

• Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.
  Hirano T, Ishihara K, Hibi M. Hirano T, et al. Oncogene. 2000 May 15;19(21):2548-56. doi: 10.1038/sj.onc.1203551. Oncogene. 2000. PMID: 10851053 Review.
• The role of STATs in myeloid differentiation and leukemia.
  Coffer PJ, Koenderman L, de Groot RP. Coffer PJ, et al. Oncogene. 2000 May 15;19(21):2511-22. doi: 10.1038/sj.onc.1203479. Oncogene. 2000. PMID: 10851050 Review.
• Delineation and mapping of Stat5 isoforms activated by granulocyte colony-stimulating factor in myeloid cells.
  Chakraborty A, Dyer KF, Tweardy DJ. Chakraborty A, et al. Blood Cells Mol Dis. 2000 Aug;26(4):320-30. doi: 10.1006/bcmd.2000.0309. Blood Cells Mol Dis. 2000. PMID: 11042034
• Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis.
  Silva CM. Silva CM. Oncogene. 2004 Oct 18;23(48):8017-23. doi: 10.1038/sj.onc.1208159. Oncogene. 2004. PMID: 15489919 Review.
• STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1).
  de Koning JP, Soede-Bobok AA, Ward AC, Schelen AM, Antonissen C, van Leeuwen D, Löwenberg B, Touw IP. de Koning JP, et al. Oncogene. 2000 Jul 6;19(29):3290-8. doi: 10.1038/sj.onc.1203627. Oncogene. 2000. PMID: 10918585

Cited by

• Prolonged classical NF-kappaB activation prevents autophagy upon E. coli stimulation in vitro: a potential resolving mechanism of inflammation.
  Schlottmann S, Buback F, Stahl B, Meierhenrich R, Walter P, Georgieff M, Senftleben U. Schlottmann S, et al. Mediators Inflamm. 2008;2008:725854. doi: 10.1155/2008/725854. Mediators Inflamm. 2008. PMID: 18566685 Free PMC article.
• STAT3 for Cardiac Regenerative Medicine: Involvement in Stem Cell Biology, Pathophysiology, and Bioengineering.
  Nakao S, Tsukamoto T, Ueyama T, Kawamura T. Nakao S, et al. Int J Mol Sci. 2020 Mar 12;21(6):1937. doi: 10.3390/ijms21061937. Int J Mol Sci. 2020. PMID: 32178385 Free PMC article. Review.
• Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myeloma.
  Dimberg LY, Dimberg A, Ivarsson K, Fryknäs M, Rickardson L, Tobin G, Ekman S, Larsson R, Gullberg U, Nilsson K, Öberg F, Wiklund HJ. Dimberg LY, et al. BMC Cancer. 2012 Jul 28;12:318. doi: 10.1186/1471-2407-12-318. BMC Cancer. 2012. PMID: 22838736 Free PMC article.
• Multifaceted intervention by the Hsp90 inhibitor ganetespib (STA-9090) in cancer cells with activated JAK/STAT signaling.
  Proia DA, Foley KP, Korbut T, Sang J, Smith D, Bates RC, Liu Y, Rosenberg AF, Zhou D, Koya K, Barsoum J, Blackman RK. Proia DA, et al. PLoS One. 2011 Apr 14;6(4):e18552. doi: 10.1371/journal.pone.0018552. PLoS One. 2011. PMID: 21533169 Free PMC article.
• STAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model.
  Couronné L, Scourzic L, Pilati C, Della Valle V, Duffourd Y, Solary E, Vainchenker W, Merlio JP, Beylot-Barry M, Damm F, Stern MH, Gaulard P, Lamant L, Delabesse E, Merle-Beral H, Nguyen-Khac F, Fontenay M, Tilly H, Bastard C, Zucman-Rossi J, Bernard OA, Mercher T. Couronné L, et al. Haematologica. 2013 Nov;98(11):1748-52. doi: 10.3324/haematol.2013.085068. Epub 2013 Jul 19. Haematologica. 2013. PMID: 23872306 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal